Bristol-Myers EVP Research & Early Development Rupert Vessey to depart July 2023

BRISTOL MYERS SQUIBB CO

Dr. Rupert Vessey, EVP Research and Early Development, leaves effective July 3, 2023.
Severance under Senior Executive Severance Plan; pro-rated vesting of MSUs, PSUs, and full vesting of 2019 RSU Inducement Award.
Pro-rated annual incentive payout for 2023 of $550,855.
No replacement named at this time.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rupert Vessey

Executive Vice President, Research and Early Development

BMY · BRISTOL MYERS SQUIBB CO

Effective: 2023-07-03
Filed: January 31, 2023, 6:59 PM ET

Effective July 3, 2023, Dr. Rupert Vessey, Executive Vice President, Research and Early Development, has decided to leave Bristol-Myers Squibb Company (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rupert Vessey resigned as Executive Vice President, Research and Early Development at BRISTOL MYERS SQUIBB CO.

Action: resigned
Role: Executive Vice President, Research and Early Development

Exact text from the filing

Effective July 3, 2023, Dr. Rupert Vessey, Executive Vice President, Research and Early Development, has decided to leave Bristol-Myers Squibb Company (the “Company”).

View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR

accession 0001140361-23-003577

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.